Ribosomal protein L39 pseudogene 25 (RPL39P25)

RPL39P25 is a processed pseudogene that is related to the ribosomal protein L39 gene family but does not encode a functional protein. Pseudogenes arise from gene duplication or retrotransposition events and typically lack protein-coding ability due to mutations or truncations[1][3]. There is no evidence that RPL39P25 is transcribed into a functional RNA or protein, nor is it implicated in any physiological or pathological processes. It is not considered a therapeutic target and does not have reported biological functions, disease associations, or drug interactions in the scientific literature or curated databases[1][3]. As a pseudogene, RPL39P25 is not classified as an enzyme, receptor, transporter, transcription factor, or any functional therapeutic target[1][3]. Selection of RPL39P25 as a molecular target for drug development or mechanistic studies is incorrect, as it does not code for a protein and has no known cellular or disease relevance[1][3]. Pseudogenes are generally non-functional genetic elements, often remnants of ancestral genes, and are not targeted by drugs nor serve as biomarkers or safety concerns. If you intended to inquire about the functional ribosomal protein gene, RPL39, that encodes a component of the 60S ribosomal subunit, or one of its functional paralogs, please specify, as those have distinct biological roles compared to pseudogenes[2][4].

Other names

RPL39_11_1067[3]